{"id":11517,"date":"2026-05-27T15:00:00","date_gmt":"2026-05-27T13:00:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=d8999de70e620dd093a5d968a7fce6d4"},"modified":"2026-05-27T21:13:00","modified_gmt":"2026-05-27T19:13:00","slug":"cosm-medical-announces-licensing-and-collaboration-agreement-to-advance-post-surgical-pelvic-recovery-with-personalized-gynethotics-devices","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=11517","title":{"rendered":"Cosm Medical Announces Licensing and Collaboration Agreement to Advance Post-Surgical Pelvic Recovery with Personalized Gynethotics\u2122 Devices"},"content":{"rendered":"<p>\nCosm Medical Corp. (<a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cosm.care&amp;esheet=54541157&amp;newsitemid=20260527607633&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.cosm.care&amp;index=1&amp;md5=9711867a703f842a814b862b1e29648a\" rel=\"nofollow\" shape=\"rect\">https:\/\/www.cosm.care<\/a>), a leader in personalized gynecological medical devices, has entered into a licensing and collaboration agreement with two leading academic medical centers to develop Gynethotics\u2122 Recovery\u2014personalized intravaginal devices for post-surgical pelvic recovery following reconstructive surgery.<\/p><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260527607633\/en\/2813577\/4\/COSM_logo_primarypurple.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260527607633\/en\/2813577\/22\/COSM_logo_primarypurple.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260527607633\/en\/2813577\/4\/COSM_logo_primarypurple.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260527607633\/en\/2813577\/21\/COSM_logo_primarypurple.jpg\" \/><\/a><p>TORONTO--(BUSINESS WIRE)--<a href=\"https:\/\/twitter.com\/hashtag\/CosmMedical?src=hash\" >#CosmMedical<\/a>--Cosm Medical Corp., a medical technology company specializing in personalized gynecological devices, today announced that it has entered into a licensing and collaboration agreement with Duke Health and Mayo Clinic to develop and commercialize a new class of personalized devices designed for post-surgical recovery.<\/p><p>\nUnder the agreement, Cosm Medical has licensed intellectual property from both institutions related to a novel device design and clinical use following pelvic reconstructive surgery. The collaboration will focus on product evaluation, clinical validation, and the potential commercialization of personalized recovery devices intended to support healing, improve anatomical outcomes, and enhance patient comfort and quality of life.<\/p><p>\n<b>Advancing Precision in Post-Surgical Pelvic Care\n<br\/><\/b>Gynethotics\u2122 Recovery builds on Cosm Medical\u2019s patented digital gynecology platform, which integrates medical imaging and 3D-printing to deliver personalized biocompatible devices. The new Gynethotics\u2122 Recovery line is designed to add new ways to advance the widespread use of non-invasive devices in pelvic care.<\/p><p>\nThis initiative seeks to reflect a broader shift in healthcare toward precision medicine and, within pelvic health, where personalized devices can address anatomical variability and improve outcomes compared to traditional one-size-fits-all pessaries and beyond.<\/p><p>\n\u201cWe see personalization for precision as the next frontier in pelvic health,\u201d said Derek Sham, Founder and CEO of Cosm Medical. \u201cPrecision unlocks new clinical applications for medical devices in gynecology. The goal of this collaboration is to advance a standard of care aligned with fields like orthopaedics and dentistry, where custom-fabricated devices are already well established. By combining clinical expertise with a scalable precision care platform, we believe Gynethotics\u2122 Recovery has the potential to redefine post-surgical healing and improve outcomes for patients worldwide.\u201d<\/p><p>\n\u201cTissue remodeling and personalized support can play a key role in improving surgical outcomes and patient experience,\u201d said Dr Cassandra Kisby, Assistant Professor of Obstetrics and Gynecology at Duke University\u2019s School of Medicine. \u201cMoving beyond one-size-fits-all, historically rooted practices toward an evidence-driven, personalized paradigm marks a pivotal shift in surgical recovery.\u201d<\/p><p>\n<b>About Cosm Medical\n<br\/><\/b>Cosm Medical Corp. (<a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.cosm.care&amp;esheet=54541157&amp;newsitemid=20260527607633&amp;lan=en-US&amp;anchor=www.cosm.care&amp;index=2&amp;md5=224c7e342b8d0e13d4991bbf464377f1\" rel=\"nofollow\" shape=\"rect\">www.cosm.care<\/a>) is a Toronto-based medical technology company pioneering precision pelvic care through its digital gynecology platform, enabling the fabrication of personalized gynecological devices (Gynethotics\u2122) for conditions such as pelvic organ prolapse, incontinence, and post-surgical recovery. Cosm\u2019s mission is to bring personalized care to women\u2019s pelvic health.<\/p><p>\nFor more information, visit: <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.cosm.care&amp;esheet=54541157&amp;newsitemid=20260527607633&amp;lan=en-US&amp;anchor=www.cosm.care&amp;index=3&amp;md5=0ed554f60890f77b34e8ba1d9d29006a\" rel=\"nofollow\" shape=\"rect\">www.cosm.care<\/a><\/p><p>\n<i>Mayo Clinic has a financial interest in the technology referenced in this press release. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research.<\/i><\/p><p>\n<i>Duke Health has a financial interest in the technology referenced in this press release. Duke Health will use any revenue it receives to support its not-for-profit mission in patient care, education and research.<\/i><\/p><br\/> <b>Contacts<\/b> <br\/><p>\nMedia Contact:\n<br\/>Derek Sham, Founder and CEO\n<br\/>Cosm Medical Corp.\n<br\/><a  href=\"mailto:info@cosm.care\" rel=\"nofollow\" shape=\"rect\">info@cosm.care<\/a> | +1 (888) 589-2676<\/p>","protected":false},"excerpt":{"rendered":"<p>Cosm Medical Corp. (https:\/\/www.cosm.care), a leader in personalized gynecological medical devices, has entered into a licensing and collaboration agreement with two leading academic medical centers to develop Gynethotics\u2122 Recovery\u2014personalized intrav&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-11517","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/11517","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11517"}],"version-history":[{"count":2,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/11517\/revisions"}],"predecessor-version":[{"id":11969,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/11517\/revisions\/11969"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11517"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11517"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11517"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}